文献速递生殖医学

法国国家健康数据系统:ART取卵女性住院情况概览

Overview of hospitalizations in women undergoing oocyte retrieval for ART in the French national health data system.
PubMed 文献 · Hum Reprod · 2021-01-01

结果显示不孕组取卵后卵巢过度刺激综合征、附件扭转、静脉血栓等发生率显著升高,但总体发生率相对取卵总数较低。

要点

  • 不孕组取卵后OHSS住院率162/万人月,显著高于取卵前6/万人月。
  • 生育力保存组取卵后静脉血栓住院率59/万人月,显著高于取卵前4/万人月。
  • 供卵组取卵后OHSS住院率116/万人月,显著高于取卵前0/万人月。

核心结论

  • ART取卵后部分并发症住院发生率显著升高,但相对取卵总数总体发生率较低。

研究设计与样本

  • 按取卵指征分为不孕(IF)、供卵(OD)和生育力保存(FP)三个亚组。

主要发现

  • 不孕组取卵后 vs 取卵前住院发生率(每万人月):OHSS 162 vs 6,附件扭转14 vs 3,静脉血栓8 vs 1,动脉血栓3 vs 1,创伤2 vs 1,感染61 vs 87。
  • 生育力保存组取卵后 vs 取卵前:OHSS 55 vs 0,静脉血栓59 vs 4,感染176 vs 56。
  • 供卵组取卵后 vs 取卵前:OHSS 116 vs 0,出血24 vs 0。
  • OHSS、附件扭转和静脉血栓的发生率升高仅部分可由妊娠解释。

临床怎么用

  • 临床应关注ART取卵后OHSS、血栓和附件扭转等并发症的监测,尤其是不孕和生育力保存人群。

局限性

  • 法国国家健康数据系统存在编码错误风险。
  • 缺乏部分个人信息和风险因素,无法进行风险调整。
  • 仅分析导致住院的并发症,可能低估并发症发生率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the incidence rate of complications in women undergoing ART procedures compared to the period prior to their first oocyte retrieval? SUMMARY ANSWER: The study shows a significant increase in the post-ART incidence rate of some complications but a low overall rate of occurrence relative to the total number of oocyte retrievals. WHAT IS KNOWN ALREADY: ART, widely used in Europe, accounts for 3.3% of births in France. The various studies of ART complications are fairly reassuring, showing relatively low overall complication rates but only few studies have used exhaustive national registers. STUDY DESIGN, SIZE, DURATION: The cohort for this study was identified from the comprehensive French national hospital-discharge database and includes women under 50 years with a first oocyte retrieval (T0) in 2012-2017, classified in three population subgroups according to the indication for oocyte retrieval: infertility (IF), oocyte donation (OD), and fertility preservation (FP). This study includes 156 916 women whose first oocyte retrieval occurred in 2012-2017 and 542 775 hospitalizations in 2010-2019 (excluding first retrieval). PARTICIPANTS/MATERIALS, SETTING, METHODS: Hospitalizations for complications or others events (oocyte retrieval, delivery, pregnancy loss, and death in the hospital) during the 2 years before (control period) and after their first oocyte retrieval (post-oocyte retrieval period) were compared and expressed per 10 000 person-months (pm). MAIN RESULTS AND THE ROLE OF CHANCE: In the IF subgroup, incidence rates were significantly higher after (vs before) retrieval for hospitalized ovarian hyperstimulation syndrome (OHSS) (162 vs 6/10 000 pm), adnexal torsion (14 vs 3), venous thrombosis (8 vs 1), arterial thrombosis (3 vs 1), trauma (2 vs 1), and significantly lower for infections (61 vs 87). The higher incidences of OHSS, adnexal torsion and venous thrombosis could only partially be explained by the occurrence of pregnancy.In the FP subgroup, incidence increased significantly after (vs before) retrieval for hospitalized OHSS (55 vs 0), venous thrombosis (59 vs 4), and infections (176 vs 56). For the OD subgroup, hospitalized OHSS (116 vs 0) and bleeding (24 vs 0) were significantly higher after (vs before) retrieval. LIMITATIONS, REASONS FOR CAUTION: The French national health data system, despite all its advantages, present some limitations such as the risk of coding errors. The unavailability of some personal information and the absence of consideration of risk factors prevented us from adjusting the risk. Finally, only complications resulting in hospitalization were analyzed which probably leads to their underestimation. WIDER IMPLICATIONS OF THE FINDINGS: The use of medico-administrative bases will be a valuable tool in public health and will furnish a better overview of the complications. Further studies are needed to complete this analysis. Adding information on drugs would help to better define T0 and less severe complications. STUDY FUNDING/COMPETING INTEREST(S): N/A. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Lemardeley G, Pirrello O, Dieterlé S, et al. Overview of hospitalizations in women undergoing oocyte retrieval for ART in the French national health data system. Hum Reprod. 2021. PMID: 34282458. doi:10.1093/humrep/deab147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。